Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Body fat and cardiovascular disease risk in postmenopausal women with normal body mass index: The Women's Health Initiative
    Meeting Abstract

    Chen, G. C.; Arthur, R.; Iyengar, N. M.; Kamensky, V.; Xue, X.; Wassertheil-Smoller, S.; Allison, M. A.; Shadyab, A. H.; Wild, R. A.; Sun, Y.; more...
    Circulation (2019)

    Fulltext@MSK | Save
  • Non-canonical, clinical ESR1 mutations promote resistance to antiestrogen therapies
    Meeting Abstract

    Toy, W.; Carlson, K. E.; Martin, T. A.; Razavi, P.; Berger, M.; Baselga, J.; Greene, G.; Katzenellenbogen, J.; Chandarlapaty, S.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Phase Ib/II study of capecitabine 7/7 schedule with neratinib in patients with HER2-positive metastatic breast cancer (MBC)
    Meeting Abstract

    Wang, R.; Singh, J.; Sterlin, V.; Goldstein, M.; Lake, D.; Wong, S.; Baselga, J.; Norton, L.; Dang, C.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • A pilot randomized usual care controlled study of yoga for persistent chemotherapy-induced peripheral neuropathy (CIPN) in breast and gynecological cancer survivors
    Meeting Abstract

    Zhi, W. I.; Leeolou, M. C.; Piulson, L.; Chen, P.; Patterson, C.; Paul, T.; Patil, S.; Mao, J. J.; Bao, T.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • The impact of breast cancer surgery on quality of life: Long term results from E5103
    Meeting Abstract

    Rosenberg, S. M.; O'Neill, A.; Sepucha, K.; Miller, K. D.; Dang, C. T.; Northfelt, D. W.; Sledge, G. W.; Schneider, B. P.; Partridge, A. H.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Influence of prognostic factors on outcomes among metastatic breast cancer patients treated with CDK4&6 inhibitors in routine clinical practice
    Meeting Abstract

    Saverno, K. R.; Carter, G. C.; Li, L.; Battiato, L. A.; Huang, Y. J.; Smyth, E. N.; Price, G. L.; Sheffield, K. M.; Baxi, S. S.; Kuk, D.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Transient state change, but not permanent subtype change, after HER2-targeted therapy for HER2-positive breast cancer
    Meeting Abstract

    Tanioka, M.; Parker, J. S.; Henry, L. N.; Tolaney, S.; Dang, C.; Krop, I. E.; Harris, L.; Polley, M.; Berry, D. A.; Winer, E. P.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Dose justification for DS-8201a, a HER2-targeted antibody-drug conjugate, for HER2-positive breast cancer: Observed clinical data and exposure-response analyses
    Meeting Abstract

    Tamura, K.; Modi, S.; Tsurutani, J.; Takahashi, S.; Krop, I. E.; Iwata, H.; Wada, R.; Yin, O.; Garimella, T.; Sugihara, M.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Characterization, monitoring and management of interstitial lung disease in patients with metastatic breast cancer: Analysis of data available from multiple studies of DS-8201a, a HER2-targeted antibody drug conjugate with a topoisomerase I inhibitor payload
    Meeting Abstract

    Powell, C. A.; Camidge, D. R.; Gemma, A.; Kusumoto, M.; Baba, T.; Kuwano, K.; Bankier, A.; Kiura, K.; Tamura, K.; Modi, S.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • A phase I trial of sorafenib with whole brain radiotherapy (WBRT) in breast cancer patients with brain metastases and a correlative study of FLT-PET brain imaging in patients receiving WBRT with or without sorafenib
    Meeting Abstract

    Morikawa, A.; Jhaveri, K.; Grkovski, M.; Tang, K.; Humm, J. L.; Holodny, A.; Beal, K.; Schoder, H.; Seidman, A. D.
    Cancer Research (2019)

    Fulltext@MSK | Save